Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Northwest Biotherapeutics (NWBO)
OTHER OTC:NWBO
Northwest Biotherapeutics (NWBO) Stock Price & Analysis
323 Followers
NWBO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.40 - $1.27
Previous Close$0.91
Volume2.48M
Average Volume (3M)2.34M
Market Cap
$1.02B
Enterprise Value$1.05B
Total Cash (Recent Filing)$1.42M
Total Debt (Recent Filing)$30.76M
Price to Earnings (P/E)-11.1
Beta-0.03
Next Earnings
May 16, 2018EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding1,086,771,876
10 Day Avg. Volume4,830,144
30 Day Avg. Volume2,335,319
Standard Deviation0.27
R-Squared0.00428
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)-16.20
Price to Sales (P/S)5227.93
Price to Cash Flow (P/CF)-22.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.01K
Enterprise Value/Gross Profit7.24K
Enterprise Value/Ebitda-12.50
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Northwest Biotherapeutics News
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NWBO FAQ
What was Northwest Biotherapeutics’s price range in the past 12 months?
Northwest Biotherapeutics lowest stock price was $0.40 and its highest was $1.27 in the past 12 months.
What is Northwest Biotherapeutics’s market cap?
Currently, no data Available
When is Northwest Biotherapeutics’s upcoming earnings report date?
Northwest Biotherapeutics’s upcoming earnings report date is May 16, 2018 which is 1967 days ago.
How were Northwest Biotherapeutics’s earnings last quarter?
Currently, no data Available
Is Northwest Biotherapeutics overvalued?
According to Wall Street analysts Northwest Biotherapeutics’s price is currently Overvalued.
Does Northwest Biotherapeutics pay dividends?
Northwest Biotherapeutics does not currently pay dividends.
What is Northwest Biotherapeutics’s EPS estimate?
Northwest Biotherapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Northwest Biotherapeutics have?
Northwest Biotherapeutics has 1,121,070,900 shares outstanding.
What happened to Northwest Biotherapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Northwest Biotherapeutics?
Among the largest hedge funds holding Northwest Biotherapeutics’s share is Fisher Asset Management LLC. It holds Northwest Biotherapeutics’s shares valued at N/A.
---
Northwest Biotherapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
NWBO Sentiment 100%
Sector Average 69%
Sector Average 69%
Crowd Wisdom
Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▲ 0.4%
Last 30 Days ▲ 0.4%
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.85%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
3.32%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Northwest Biotherapeutics
Northwest Biotherapeutics, Inc. is a clinical stage biotechnology company. The firm engages in the development of cancer vaccines designed to treat solid tumor cancers. It also offers a platform technology for DCVax dendritic cell-based vaccines. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.
---
---